Literature DB >> 26097601

Whether Alzheimer's diseases related genes also differently express in the hippocampus of Ts65Dn mice?

Bin Zhang1, Qiuwei Wang1, Tingting Miao1, Bin Yu1, Pei Yuan1, Jing Kong1, Beiyi Lu1.   

Abstract

BACKGROUND: Down syndrome is a condition which extra genetic material causes delays in child development, both mentally and physically. Strengthening the study of the neural defects of DS is of great significance.
METHODS: Ts65Dn mice were used in this study. We removed the brain and isolated their hippocampus. We customized 54 genes in one PCR arrays, included some important genes related to Alzheimer's disease. The expression of genes were detected by RT-PCR.
RESULTS: PCR arrays contained 54 genes related to Alzheimer's disease. After real-time PCR, three genes (Nae1, APP and Mapt) expressed differently in the hippocampus of Ts65Dn, compared with the normal mice. Nae1 was decreased significantly, while APP and Mapt were increased obviously. The levels of fold-changes of Nae1, APP and Mapt were 86.19, 4.49 and 2.89 respectively. Significantly different levels of expression were found in the Ts65Dn mice compared with the normal control group (P=0.00 for Nae1, P=0.02 for APP, P=0.01 for Mapt respectively).
CONCLUSIONS: There are differential expressed genes in the hippocampus of Ts65Dn mice that may be closely related to Alzheimer's disease. PCR array technology was used in the screening and identification of these genes.

Entities:  

Keywords:  Alzheimer’s disease; Down syndrome; PCR array; Ts65Dn; hippocampus

Mesh:

Substances:

Year:  2015        PMID: 26097601      PMCID: PMC4466988     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  18 in total

Review 1.  Dementia and mortality in persons with Down's syndrome.

Authors:  A Coppus; H Evenhuis; G-J Verberne; F Visser; P van Gool; P Eikelenboom; C van Duijin
Journal:  J Intellect Disabil Res       Date:  2006-10

2.  A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.

Authors:  Thorlakur Jonsson; Jasvinder K Atwal; Stacy Steinberg; Jon Snaedal; Palmi V Jonsson; Sigurbjorn Bjornsson; Hreinn Stefansson; Patrick Sulem; Daniel Gudbjartsson; Janice Maloney; Kwame Hoyte; Amy Gustafson; Yichin Liu; Yanmei Lu; Tushar Bhangale; Robert R Graham; Johanna Huttenlocher; Gyda Bjornsdottir; Ole A Andreassen; Erik G Jönsson; Aarno Palotie; Timothy W Behrens; Olafur T Magnusson; Augustine Kong; Unnur Thorsteinsdottir; Ryan J Watts; Kari Stefansson
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962

Review 3.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  The four ages of Down syndrome.

Authors:  Alan H Bittles; Carol Bower; Rafat Hussain; Emma J Glasson
Journal:  Eur J Public Health       Date:  2006-07-19       Impact factor: 3.367

Review 5.  Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology.

Authors:  R W Mahley; Y Huang
Journal:  Acta Neurol Scand Suppl       Date:  2006

6.  A real-time PCR array for hierarchical identification of Francisella isolates.

Authors:  Kerstin Svensson; Malin Granberg; Linda Karlsson; Vera Neubauerova; Mats Forsman; Anders Johansson
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

Review 7.  Alzheimer's disease genetics: from the bench to the clinic.

Authors:  Celeste M Karch; Carlos Cruchaga; Alison M Goate
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

8.  Are the cognitive functions of children with Down syndrome related to their participation?

Authors:  Tanya Rihtman; Esti Tekuzener; Shula Parush; Alex Tenenbaum; Steven J Bachrach; Asher Ornoy
Journal:  Dev Med Child Neurol       Date:  2009-09-16       Impact factor: 5.449

Review 9.  Genetic markers for diagnosis and pathogenesis of Alzheimer's disease.

Authors:  Dong Hee Kim; Seung Hyeon Yeo; Jeong-Min Park; Ji Ye Choi; Tae-Hee Lee; Soon Yong Park; Mee Sun Ock; Jungwoo Eo; Heui-Soo Kim; Hee-Jae Cha
Journal:  Gene       Date:  2014-05-15       Impact factor: 3.688

10.  MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies.

Authors:  Daniah Trabzuni; Selina Wray; Jana Vandrovcova; Adaikalavan Ramasamy; Robert Walker; Colin Smith; Connie Luk; J Raphael Gibbs; Allissa Dillman; Dena G Hernandez; Sampath Arepalli; Andrew B Singleton; Mark R Cookson; Alan M Pittman; Rohan de Silva; Michael E Weale; John Hardy; Mina Ryten
Journal:  Hum Mol Genet       Date:  2012-06-20       Impact factor: 6.150

View more
  2 in total

Review 1.  Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches.

Authors:  Clíona Farrell; Paige Mumford; Frances K Wiseman
Journal:  Front Neurosci       Date:  2022-06-07       Impact factor: 5.152

2.  Data-Driven Analysis of Age, Sex, and Tissue Effects on Gene Expression Variability in Alzheimer's Disease.

Authors:  Lavida R K Brooks; George I Mias
Journal:  Front Neurosci       Date:  2019-04-24       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.